8-K: Masimo Appoints Former Disney CEO Bob Chapek to Board of Directors

Masimo Corporation has appointed Robert A. Chapek, former CEO of The Walt Disney Company, to its Board of Directors, effective January 15, 2024.

Summary

• Masimo Corporation has appointed Robert A. Chapek to its Board of Directors as a Class I director, effective January 15, 2024.
• Mr. Chapek brings nearly 30 years of experience from The Walt Disney Company, including serving as CEO from February 2020 to November 2022.
• He will receive an annual cash compensation of $70,000 for his board service.
• Mr. Chapek will also receive $200,000 in restricted stock units annually, vesting one year from the grant date.
• He was also granted an additional $200,000 in restricted stock units upon appointment, vesting on January 15, 2025.
• These appointment RSUs will fully vest upon a change of control of Masimo.
• Masimo has entered into a standard indemnity agreement with Mr. Chapek.
• There are no family relationships between Mr. Chapek and any other Masimo director or executive officer.

Sentiment

Score: 8

Explanation: The appointment of a high-profile executive is generally viewed positively, suggesting a strong outlook for the company. The compensation package is standard and does not raise any concerns.

Positives

• The appointment of Robert A. Chapek, a seasoned executive with experience at a major media and entertainment company, could bring valuable insights and strategic guidance to Masimo.
• Mr. Chapek's experience in consumer products and content distribution could be beneficial as Masimo expands its consumer health offerings.
• The compensation structure, including cash and stock options, aligns Mr. Chapek's interests with the company's long-term performance.

Risks

• The document does not explicitly mention any risks associated with the appointment of Mr. Chapek.
• There is a general risk that any new board member may not fully integrate with the existing board or contribute as expected.

Future Outlook

Masimo expects to benefit from Mr. Chapek's experience as they execute their hospital to home strategy.

Management Comments

• Mr. Chapek stated he is 'thrilled to join the Masimo Board' and looks forward to helping advance the company's growth.
• Joe Kiani, Chairman and CEO of Masimo, said they are 'honored to have Bob join the Board' and expect to benefit greatly from his role.

Industry Context

The appointment of a high-profile executive from the media and entertainment industry suggests Masimo is looking to expand its reach beyond traditional medical technology and into consumer health and wellness markets.

Comparison to Industry Standards

• The compensation package for Mr. Chapek, including cash and stock options, is consistent with standard practices for non-employee directors at publicly traded companies.
• The appointment of a former CEO from a large, well-known company is not uncommon for companies seeking to enhance their board's expertise and strategic guidance.
• Masimo's move to bring in an executive with experience in consumer-facing businesses is similar to other medical technology companies that are expanding into the consumer health space, such as Apple with its health features on the Apple Watch and Google with its Fitbit acquisition.

Management Changes

Related Party Transactions

• Mr. Chapek has not engaged in any transaction that would be reportable as a related party transaction.

Stakeholder Impact

• Shareholders may view the appointment of Mr. Chapek positively, potentially leading to increased confidence in the company's strategic direction.
• Employees may see this as a positive development, indicating the company's commitment to growth and innovation.
• Customers may benefit from Masimo's expansion into consumer health, potentially leading to new and improved products and services.

Next Steps

• Mr. Chapek will begin his service on the Board of Directors.
• He will receive his annual cash compensation and stock grants as outlined in the document.
• The Appointment RSU will vest on January 15, 2025, subject to his continued service.

Key Dates

Keywords

Board of Directors, Robert Chapek, Masimo, Corporate Governance, Executive Appointment, Compensation, Restricted Stock Units, Disney, Medical Technology